Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/224748


Wound Treatments in China


Description: The Wound Treatments in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: sticking plasters, other wound treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?
- Get a detailed picture of the wound treatments industry
- Identify growth sectors and factors driving change
- Understand the competitive environment, the market’s major players and leading brands
- Use five-year forecasts to assess how the market is predicted to develop


Contents: Wound Treatments in China
Euromonitor International
September 2009
List of Contents and Tables
Sector Data
Table 1 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 2 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 3 Wound Treatments Company Shares by Value 2004-2008
Table 4 Wound Treatments Brand Shares by Value 2005-2008
Table 5 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 6 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
Amway (china) Co Ltd
Strategic Direction
Key Facts
Summary 1 Amway (China) Co Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Amway (China) Co Ltd: Competitive Position 2008
Bristol-Myers Squibb (shanghai) Trading Co Ltd
Strategic Direction
Key Facts
Summary 3 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Key Facts
Company Background
Production
Summary 4 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Production Statistics 2008
Competitive Positioning
Summary 5 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Competitive Position 2008
GlaxoSmithKline (tianjin) Pharm Co Ltd
Strategic Direction
Key Facts
Summary 6 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Key Facts
Company Background
Production
Summary 7 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Production Statistics 2008
Competitive Positioning
Summary 8 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Competitive Position 2008
Jiangzhong Pharmaceutical Co
Strategic Direction
Key Facts
Summary 9 Jiangzhong Pharmaceutical Co Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 10 Jiangzhong Pharmaceutical Co Ltd: Competitive Position 2008
Sanjiu Enterprise Group
Strategic Direction
Key Facts
Summary 11 Sanjiu Enterprise Group: Key Facts
Company Background
Production
Competitive Positioning
Summary 12 Sanjiu Enterprise Group: Competitive Position 2008
Tianjin Tianshi Biological Development Co Ltd
Strategic Direction
Key Facts
Summary 13 Tianjin Tianshi Biological Development Co Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 14 Tianjin Tianshi Biological Development Co Ltd: Competitive Position 2008
Tibet Linzhi Qizheng Tibetan Medicine Fty
Strategic Direction
Key Facts
Summary 15 Tibet Linzhi Qizheng Tibetan Medicine Fty: Key Facts
Company Background
Production
Summary 16 Tibet Linzhi Qizheng Tibetan Medicine Fty: Production Statistics 2007
Competitive Positioning
Summary 17 Tibet Linzhi Qizheng Tibetan Medicine Fty: Competitive Position 2008
Wyeth Pharmaceutical Co Ltd
Strategic Direction
Key Facts
Summary 18 Wyeth Pharmaceutical Co Ltd: Key Facts
Company Background
Production
Summary 19 Wyeth Pharmaceutical Co Ltd: Production Statistics 2008
Competitive Positioning
Summary 20 Wyeth Pharmaceutical Co Ltd: Competitive Position 2008
Xian Janssen Pharmaceutical Ltd
Strategic Direction
Key Facts
Summary 21 Xian Janssen Pharmaceutical Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 22 Xian Janssen Pharmaceutical Ltd: Competitive Position 2008
Yunnan Baiyao Group Co Ltd
Strategic Direction
Key Facts
Summary 23 Yunnan Baiyao Group Co Ltd: Key Facts
Company Background
Production
Summary 24 Yunnan Baiyao Group Co Ltd: Production Statistics 2008
Competitive Positioning
Summary 25 Yunnan Baiyao Group Co Ltd: Competitive Position 2008
Executive Summary
Growing Health Awareness and Disposable Incomes Fuel Growth
Vitamins and Dietary Supplements Lead Growth
Amway Leads Fragmented OTC Healthcare
Chemists/pharmacies Lead But Direct Selling Grows Fastest
Steady Growth for Forecast Period
Key Trends and Developments
Rising Health-consciousness and Self-medication
Convenience Becomes Increasingly Important
Lifestyle Changes Shape Growth
Players Increasingly Focus on Specific Consumer Targets
Deep-rooted Tradition Impacts OTC Healthcare
Territory Key Trends and Developments
East China
Mid China
North and Northeast China
Northwest China
South China
Southwest China
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 8 Life Expectancy at Birth 2003-2008
Market Data
Table 9 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 10 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 11 Sales of OTC Healthcare by Region: Value 2003-2008
Table 12 Sales of OTC Healthcare by Region: % Value Growth 2003-2008
Table 13 OTC Healthcare Company Shares by Value 2004-2008
Table 14 OTC Healthcare Brand Shares by Value 2005-2008
Table 15 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 16 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 17 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 18 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Table 19 Forecast Sales of OTC Healthcare by Region: Value 2008-2013
Table 20 Forecast Sales of OTC Healthcare by Region: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 26 OTC Healthcare Switches 2005-2007
Definitions
Summary 27 Research Sources


Summary: Sustained growth in 2005 supported by increasing preference for self-medication
The market for OTC healthcare in China saw growth of approaching 11% in current value terms in 2005, underpinned by the continued rise in the preference of consumers to self-medicate. According to the Survey of State Hygiene Service in 2003, almost 45% of the population in Chinese cities and towns, and 79% of the population in rural areas, have no medical insurance, which means they cannot reimburse their medical costs.

Thus these consumers tend to purchase medicines themselves instead of seeing a doctor’s advice, mainly due to the lower cost in the retail channel. On the other hand, while consumers in cities are able to reimburse the medical expenses, they are also willing to purchase medicines on an OTC basis for added convenience.


Companies Mentioned Companies Mentioned Include: - Amway (China) Co Ltd - Qingdao Jiante Biological Investment Co Ltd - Wyeth Pharmaceutical Co Ltd - Bristol-Myers Squibb (Shanghai) Trading Co Ltd - Harbin Pharmaceutical Group - Joincare Pharmaceutical Group Industry Co Ltd - Minsheng Pharmaceutical Group - Perfect (China) Co Ltd - Xian Janssen Pharmaceutical Ltd - GlaxoSmithKline (Tianjin) Pharm Co Ltd - Panlong Yunhai Pharmaceutical Corp - Shanghai Green Valley Group Co Ltd - Shanghai Johnson & Johnson Pharmaceutical Ltd - Dyne Pharm Co Ltd - Chiatai Qing Chun Bao Pharm Co Ltd - Jilin Xiuzheng Pharmaceutical Co Ltd - Vital (Sichuan) Biotech Ltd - Guangxi Jin Sang Zi Pharm Co - Sanjiu Enterprise Group - Shandong Bausch & Lomb Freda Pharmaceutical Co Ltd - Guangxi Guilin Sanjin Medicine Group - Jiangzhong Pharmaceutical Co - Beijing Zizu Pharm Co Ltd - Shanghai Jiao Da Onlly Co Ltd - Nin Jiom Medicine Mfy (Hong Kong) Ltd - Jilin Gankang Pharmaceutical Co Ltd - Yangshengtang Co Ltd - Guangdong Shunde Hong Fu Loi Healthcare Product Co Ltd - Tibet Linzhi Qizheng Tibetan Medicine Fty - Cadbury (China) Food Co - Shandong Dong-E E-Jiao Co Ltd - Shenzhen Tai Tai Pharmaceutical Co Ltd


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/224748

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 25/11/2009 12:55:11
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Wound Treatments in China
Web Address:
http://www.researchandmarkets.com/reports/224748
Office Code:
OC8HJNMPMSTQQ

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €675.00
Electronic (PDF) - Site License €1,350.00
Electronic (PDF) - Enterprisewide €2,025.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 25/11/2009 12:55:11

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)